Immunic (IMUX) Preferred Dividend Payments (2013 - 2014)
Immunic (IMUX) reported Preferred Dividend Payments of $4.7 million for Q2 2014, up 323.5% on a YoY basis from $1.1 million in Q2 2013, and up 54.92% sequentially from $3.0 million in Q1 2014.
Immunic (IMUX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Immunic (IMUX) has 2 years of Preferred Dividend Payments data on file, last reported at $4.7 million in Q2 2014.
- For the quarter ending Q2 2014, Preferred Dividend Payments rose 323.5% year-over-year to $4.7 million; the trailing twelve-month figure through Sep 2015 stood at $4.7 million (up 27.55% YoY), and the FY2014 full-year result was $4.4 million, up 6790.62% from the prior year.
- Preferred Dividend Payments rose to $4.7 million in Q2 2014, from $3.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $4.7 million in Q2 2014 to a low of -$4.1 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 4.72 Mn |
| Mar 31, 2014 | 3.05 Mn |
| Dec 31, 2013 | -4.07 Mn |
| Sep 30, 2013 | 2.05 Mn |
| Jun 30, 2013 | 1.12 Mn |
| Mar 31, 2013 | 3,000.00 |